123 related articles for article (PubMed ID: 16039891)
1. A review of the effects of therapy on growth and bone mineralization in children with congenital adrenal hyperplasia.
Gallagher MP; Levine LS; Oberfield SE
Growth Horm IGF Res; 2005 Jul; 15 Suppl A():S26-30. PubMed ID: 16039891
[TBL] [Abstract][Full Text] [Related]
2. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
3. Growth, bone mineral accretion, and adrenal function in glucocorticoid-treated infants with hemangiomas-- a retrospective study.
Lomenick JP; Backeljauw PF; Lucky AW
Pediatr Dermatol; 2006; 23(2):169-74. PubMed ID: 16650230
[TBL] [Abstract][Full Text] [Related]
4. The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia.
Girgis R; Winter JS
J Clin Endocrinol Metab; 1997 Dec; 82(12):3926-9. PubMed ID: 9398689
[TBL] [Abstract][Full Text] [Related]
5. [11beta-hydroxylase deficiency: improvement of final height with growth hormone and gonadotropin-releasing hormone analog].
Orío Hernández M; Yebra Yebra J; Bezanilla López C; Gracia Bouthelier R
An Pediatr (Barc); 2007 Aug; 67(2):153-6. PubMed ID: 17692261
[TBL] [Abstract][Full Text] [Related]
6. Growth in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Dörr HG
Horm Res; 2007; 68 Suppl 5():93-9. PubMed ID: 18174719
[TBL] [Abstract][Full Text] [Related]
7. [Patterns of growth in congenital adrenal hyperplasia. Correlation between glucocorticoid therapy and stature].
Igea JM; Lóridan L; Martul P; Ferrández A; Mayayo E; Rodríguez M; Oyarzábal M; Elcarte R; Luzuriaga C
An Esp Pediatr; 1988 Oct; 29 Suppl 35():9-12. PubMed ID: 3272842
[No Abstract] [Full Text] [Related]
8. Osteocalcin in congenital adrenal hyperplasia.
Lisá L; Neradilová M; Tomásová N; Soutorová M; Zimák J
Bone; 1995 Jan; 16(1):57-9. PubMed ID: 7742084
[TBL] [Abstract][Full Text] [Related]
9. Congenital adrenal hyperplasia in adults: a review of medical, surgical and psychological issues.
Ogilvie CM; Crouch NS; Rumsby G; Creighton SM; Liao LM; Conway GS
Clin Endocrinol (Oxf); 2006 Jan; 64(1):2-11. PubMed ID: 16402922
[TBL] [Abstract][Full Text] [Related]
10. Serum osteocalcin and insulin-like growth factor I levels in children with congenital adrenal hyperplasia.
Hargitai G; Hosszú E; Halász Z; Sólyom J
Horm Res; 1999; 52(3):131-9. PubMed ID: 10725777
[TBL] [Abstract][Full Text] [Related]
11. Current and novel approaches to children and young people with congenital adrenal hyperplasia and adrenal insufficiency.
Webb EA; Krone N
Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):449-68. PubMed ID: 26051302
[TBL] [Abstract][Full Text] [Related]
12. Absence of increased height velocity in the first year of life in untreated children with simple virilizing congenital adrenal hyperplasia.
Claahsen-van der Grinten HL; Noordam K; Borm GF; Otten BJ
J Clin Endocrinol Metab; 2006 Apr; 91(4):1205-9. PubMed ID: 16464952
[TBL] [Abstract][Full Text] [Related]
13. Fertility among women with classical congenital adrenal hyperplasia: report of seven cases where treatment was started after 9 years of age.
Kulshreshtha B; Marumudi E; Khurana ML; Kriplani A; Kinra G; Gupta DK; Kucheria K; Khadgawat R; Gupta N; Seith A; Ammini AC
Gynecol Endocrinol; 2008 May; 24(5):267-72. PubMed ID: 18569031
[TBL] [Abstract][Full Text] [Related]
14. Growth in disorders of adrenal hyperfunction.
Magiakou MA
Pediatr Endocrinol Rev; 2004 Aug; 1 Suppl 3():484-9. PubMed ID: 16444179
[TBL] [Abstract][Full Text] [Related]
15. Substitution therapy in adult patients with congenital adrenal hyperplasia.
Reisch N
Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):33-45. PubMed ID: 25617171
[TBL] [Abstract][Full Text] [Related]
16. Audit of management of children and adolescents with congenital adrenal hyperplasia as per recent Endocrine Society guidelines.
S L; Krishna Prasad H; Ramjee B; Venugopalan L; Ganapathy N; Paramasamy B
Pediatr Endocrinol Diabetes Metab; 2023; 29(1):10-15. PubMed ID: 36734395
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth.
Rivkees SA; Crawford JD
Pediatrics; 2000 Oct; 106(4):767-73. PubMed ID: 11015521
[TBL] [Abstract][Full Text] [Related]
18. Growth impairment in a boy with late-onset congenital adrenal hyperplasia and anorexia nervosa.
Niedziela M; Sippell W
Exp Clin Endocrinol Diabetes; 2010 Mar; 118(3):180-3. PubMed ID: 20198557
[TBL] [Abstract][Full Text] [Related]
19. Congenital adrenal hyperplasia: adolescence and transition.
Conway GS
Horm Res; 2007; 68 Suppl 5():155-7. PubMed ID: 18174736
[TBL] [Abstract][Full Text] [Related]
20. Do All Patients with Congenital Adrenal Hyperplasia Need to Be on Hydrocortisone Three Times a Day in Order to Have Normal Growth?
Logan LA; Nebesio TD; Eckert GJ; Eugster EA
Horm Res Paediatr; 2022; 95(5):461-464. PubMed ID: 35649383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
